Publication | Closed Access

The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination

VaccinationVaccinologyRecurrent Respiratory PapillomatosisPreventive MedicineVaccine DevelopmentHuman Papillomavirus VaccinesPotential HealthEconomic BenefitsPublic HealthPolyvalent VaccineMedicineCancer-associated Virus